Cargando…
Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used?
[Figure: see text]
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202496/ https://www.ncbi.nlm.nih.gov/pubmed/37213070 http://dx.doi.org/10.1093/europace/euad132 |
| _version_ | 1785045446085836800 |
|---|---|
| author | Cadrin-Tourigny, Julia Krahn, Andrew D Saba, Magdi |
| author_facet | Cadrin-Tourigny, Julia Krahn, Andrew D Saba, Magdi |
| author_sort | Cadrin-Tourigny, Julia |
| collection | PubMed |
| description | [Figure: see text] |
| format | Online Article Text |
| id | pubmed-10202496 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102024962023-05-23 Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used? Cadrin-Tourigny, Julia Krahn, Andrew D Saba, Magdi Europace Editorial [Figure: see text] Oxford University Press 2023-05-22 /pmc/articles/PMC10202496/ /pubmed/37213070 http://dx.doi.org/10.1093/europace/euad132 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Editorial Cadrin-Tourigny, Julia Krahn, Andrew D Saba, Magdi Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used? |
| title | Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used? |
| title_full | Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used? |
| title_fullStr | Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used? |
| title_full_unstemmed | Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used? |
| title_short | Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used? |
| title_sort | anti-tachycardia pacing in arvc: should a transvenous or subcutaneous system be used? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202496/ https://www.ncbi.nlm.nih.gov/pubmed/37213070 http://dx.doi.org/10.1093/europace/euad132 |
| work_keys_str_mv | AT cadrintourignyjulia antitachycardiapacinginarvcshouldatransvenousorsubcutaneoussystembeused AT krahnandrewd antitachycardiapacinginarvcshouldatransvenousorsubcutaneoussystembeused AT sabamagdi antitachycardiapacinginarvcshouldatransvenousorsubcutaneoussystembeused |